Your browser doesn't support javascript.
loading
Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular Telangiectasia.
Berger, Tyler A; Manry, Matthew W; Lindsell, Lucas B; Osher, James M; Miller, Daniel M; Foster, Robert E; Riemann, Christopher D; Petersen, Michael R; Sisk, Robert A.
Affiliation
  • Berger TA; Department of Ophthalmology, University of Cincinnati, Cincinnati, OH, USA.
  • Manry MW; Department of Ophthalmology, University of Cincinnati, Cincinnati, OH, USA.
  • Lindsell LB; Cincinnati Eye Institute, Cincinnati, OH, USA.
  • Osher JM; Department of Ophthalmology, University of Cincinnati, Cincinnati, OH, USA.
  • Miller DM; Cincinnati Eye Institute, Cincinnati, OH, USA.
  • Foster RE; Department of Ophthalmology, University of Cincinnati, Cincinnati, OH, USA.
  • Riemann CD; Cincinnati Eye Institute, Cincinnati, OH, USA.
  • Petersen MR; Department of Ophthalmology, University of Cincinnati, Cincinnati, OH, USA.
  • Sisk RA; Cincinnati Eye Institute, Cincinnati, OH, USA.
Clin Ophthalmol ; 15: 1133-1143, 2021.
Article in En | MEDLINE | ID: mdl-33758496
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: Clin Ophthalmol Year: 2021 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Language: En Journal: Clin Ophthalmol Year: 2021 Type: Article Affiliation country: United States